Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase

Laboratory Investigation

Volumn 79, Issue 4, 1999, Pages 467-475

  Nguyen, Minh ^a   Arkell, Jacky ^a   Jackson, Christopher J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; THROMBIN;

ANGIOGENESIS; ARTICLE; CELL ISOLATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MICROVASCULATURE; NORTHERN BLOTTING; PRIORITY JOURNAL; ZYMOGRAPHY;

CELL MEMBRANE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GELATINASES; HUMANS; INFANT, NEWBORN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICROCIRCULATION; SKIN; TETRADECANOYLPHORBOL ACETATE; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0032902109     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, and Murphy G (1995). Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270:30479-30485.
2. Bougharios G, Osman J, Black C, and Olsen I (1994). Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 231:69-78.
3. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, Vanwestrum SS, Crabbe T, Clements J, Dortho MP, and Murphy G (1998). The TIMP-2 membrane type 1 metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A - a kinetic study. J Biol Chem 273:871-880.
4. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Corcoran ML, Hewitt RE, Kleiner DE, and Stetler-Stevenson WG (1996). MMP-2: Expression, activation and inhibition. Enzyme Protein 49:7-19.
6. Foda HD, George S, Conner C, Drews M, Tompkins DC, and Zucker S (1996). Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: A protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 74: 538-545.
7. Hanemaaijer R, Koolwijk P, Leclercq L, Devree WJA, and Vanhinsbergh VWM (1993). Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor-alpha, interleukin-1 and phorbol ester. Biochem J 296:803-809.
8. Haralabopoulos GC, Grant DS, Kleinman HK, and Maragoudakis ME (1997). Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Am J Physiol 42:C239-C245.
9. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, and Werb Z (1986). Secretion of metalloproteinases by stimulated capillary endothelial cells. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261:2814-2818.
10. Jackson CJ, Garbett PK, Nissen B, and Schrieber L (1990). Binding of human endothelium to Ulex Europaeus I-coated dynabeads: Application to the isolation of microvascular endothelium. J Cell Sci 96:257-262.
11. Jackson CJ and Nguyen M (1997). Human microvascular differ from macrovascular endothelial cells in their expression of matrix metalloproteinases (MMPs). Int J Biochem Cell Biol 29:1167-1177.
12. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, and Seiki M (1998). TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 273:16098-16103.
13. Kolkenbrock H, Heckerkia A, Orgel D, Ulbrich N, and Will H (1997). Activation of progelatinase A and progelatinase A-TIMP-2 complex by membrane type 2 matrix metalloproteinase. Biol Chem 378:71-76.
14. Lewalle JM, Munaut C, Pichot B, Cataldo D, Baramova E, and Foidart JM (1995). Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol 165:475-483.
15. Lohi J, Lehti K, Westermarck J, Kahari VM, and Keski-Oja J (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239:239-247.
16. Maciag T, Cerundolo J, Ilsley S, Kelley PR, and Forand R (1979). An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization. Proc Natl Acad Sci USA 76:5674-5678.
17. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, and Mignatti P (1997). Control of type iv collagenase activity by components of the urokinase-plasmin system - a regulatory mechanism with cell-bound reactants. EMBO J 16:2319-2332.
18. Morris R, Winyard PG, Blake DR, and Morris CJ (1994). Thrombin in inflammation and healing: Relevance to rheumatoid arthritis. Ann Rheum Dis 53:72-79.
19. Murphy G and Crabbe T (1995). Gelatinases A and B. Methods Enzymol 248:470-484.
20. Nagase H (1997). Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
21. Nguyen M, Arkell J, and Jackson CJ (1998). Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles. J Biol Chem 273:5400-5404.
22. Sato H and Seiki M (1996). Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 119:209-215.
23. Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stevenson WS, and Seiki M (1996). Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 385:238-240.
24. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
25. Shofuda K, Moriyama K, Nishihashi A, Higashi S, Mizushima H, Yasumitsu H, Miki K, Sato H, Seiki M, and Miyazaki K (1998). Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalysed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. J Biochem 124:462-470.
26. Shofuda K, Yasumitsu H, Nishihashi A, Miki K, and Miyazaki K (1997). Expression of three membrane-type matrix metalloproteinase (MT-MMPs) in rat vascular smooth muscle cells and characterization of MTS-MMPs with and without transmembrane domain. J Biol Chem 272:9749-9754.
27. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, and Goldberg GI (1995). Mechanism of cell surface activation of 72-kda type IV collagenase: Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338.
28. Strongin AY, Marmer BL, Grant GA, and Goldberg GI (1993). Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268:14033-14039.
29. Sugiura Y, Shimada H, Seeger CR, Laug WE, and DeClerck YA (1998). Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stroma cells to their production and correlation with metastasis. Cancer Res 58:2209-2216.
30. Tsopanoglou NE, Pipili Synetos E, and Maragoudakis ME (1993). Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 264:C1302-C1307.
31. Will H, Atkinson SJ, Butler GS, Smith B, and Murphy G (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. J Biol Chem 271:17119-17123.
32. Yu AE, Hewitt RE, Kleiner DE, and Stetlerstevenson WG (1996). Molecular regulation of cellular invasion: Role of gelatinase A and TIMP-2. Biochem Cell Biol 74:823-831.
33. Zucker S, Conner C, Dimassmo Bl, Ende H, Drews M, Seiki M, and Bahou WF (1995). Thrombin induces the activation of progelatinase A in vascular endothelial cells: Physiologic regulation of angiogenesis. J Biol Chem 270:23730-23738.
34. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AP, and Cao J (1998). Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1 matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216-1222.